Secondary Logo

Journal Logo

Erratum

Pain, Mood, and Substance Abuse in HIV

Implications for Clinic Visit Utilization, Antiretroviral Therapy Adherence, and Virologic Failure

Erratum

JAIDS Journal of Acquired Immune Deficiency Syndromes: May 1, 2013 - Volume 63 - Issue 1 - p e36-e39
doi: 10.1097/QAI.0b013e3182936809
  • Free

In the article by Merlin et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 61, No. 2, pp. 164-170 entitled “Pain, Mood, and Substance Abuse in HIV: Implications for Clinic Visit Utilization, Antiretroviral Therapy Adherence, and Virologic Failure”, there were errors in the substance abuse variable. Forty-two individuals were misclassified into the current substance abuse category. Thirty-seven of these individuals are now classified as not having substance abuse and the remaining 5 have missing data. The authors have repeated all of their analyses, and the updated tables are shown below. In addition to these tables, the P value reported in the text for the interaction between pain and substance abuse in Table 2 is now 0.0029 (was 0.0022). These changes do not affect the statistical significance of any of the reported odds ratios, and do not change the conclusions of the article.

T1-29
TABLE 1-a:
Characteristics of 1521 HIV-Infected Patients Seen for Outpatient Medical Care at the UAB HIV Clinic, April 2008–June 2011
T2-29
TABLE 1-b:
Characteristics of 1521 HIV-Infected Patients Seen for Outpatient Medical Care at the UAB HIV Clinic, April 2008–June 2011
T3-29
TABLE 2:
No-show Visits
T4-29
TABLE 3:
Urgent Visit Utilization
T5-29
TABLE 4:
Adherence to Antiretroviral Therapy
T6-29
TABLE 5:
Virologic Failure

REFERENCE

Merlin JS, Westfall AO, Raper JL, et al.. Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr. 2012;61:164–170.
© 2013 Lippincott Williams & Wilkins, Inc.